Hand over computer screen

Prof. Dr. Beat Lutz

Scientific Managing Director LIR, Professor and Director of Institute of Physiological Chemistry University Medical Center of the Johannes Gutenberg-University Mainz

Kontakt

Leibniz-Institut für Resilienzforschung gGmbH

Wallstraße 7
55122 Mainz

+49 (0)6131 89448-37


Sekretariat (8:30 - 15:00)
E-Mail: verena.huber@lir-mainz.de
Telefon: +49 (0)6131-89448-77

Expertise

Behavioral Genetics in mouse. Mechanisms underlying learning and memory, and stress coping. Epigenetic mechanisms underlying behavior. Lipid signaling systems (mainly on endocannabinoids and cannabinoid receptors). Roles of the endocannabinoid system in anxiety, fear memory, stress coping, synaptic plasticity, adult neurogenesis, neural development, and energy metabolism.

General Information
Year of Birth

1961

Current Position

Scientific Managing Director and Research Group Leader Leibniz Institute for Resilience Research (LIR), Mainz, Germany

Professor and Director at Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg-University Mainz

University training and degrees
1/2002

Habilitation in Zoology at the LMU Munich, Germany (Prof. G. Neuweiler)

10/1990

Diploma for Gymnasium teacher in Chemistry, ETH, Switzerland

3/1989

Dr. sc. nat: ETH Zurich Switzerland

6/1985-03/1989

Doctorate work at the Institute for Cell Biology, ETH Zurich, Switzerland (Prof. M. Lezzi, Prof. H. Eppenberger)

5/1985

Diploma in Natural Sciences at ETH Zurich, Switzerland

9/1980-05/1985

Studies in Biochemistry at ETH Zurich, Switzerland

Advanced academic qualifications
1/2002

Habilitation in Zoology at the LMU Munich, Germany (Prof. G. Neuweiler)

Postgraduate professional career
Since 1/2020

Scientific Managing Director and Research Group Leader, Leibniz Institute for Resilience Research (LIR), Mainz, German

Since 1/2009

Director of the Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University, Mainz, Germany

Since 10/2004

W3 Professor for Physiological Chemistry, Institute of Physiological Chemistry and Pathobiochemistry, Johannes Gutenberg University, Mainz, Germany

04/1997 – 09/2004

Independent Group Leader of the Max Planck Society at the Max Planck Institute of Psychiatry, Munich, Germany

04/1995 – 03/1997

Scientist at the DKFZ, Heidelberg, Germany (Prof. G. Schütz)

04/1989 – 03/1995

Postdoctoral positions at ETH Zurich, Switzerland (Prof. M. Lezzi), Harvard Medical School, Boston, MA USA (Prof. G. Eichele), and Baylor College of Medicine, Houston, TX, USA (Prof. G. Eichele)

 

Other professional activities or honors
2016-2020

Spokesperson of the CRC1193 „Neurobiology of Resilience“

Since 2016

Tenure Commission at UM Mainz, Germany

Since 2015

Co-organizer of the International Symposium on Resilience Research

2014-2019

Member of Fachbereichsrat at UM Mainz, Germany

2014

Mechoulam Award for Outstanding Contributions to Cannabinoid Research

2011

Chair of the Gordon Research Conference “Cannabinoid Functions in the CNS”

2008 – 2014

Spokesperson of DFG Research Unit FOR926 (with A. Zimmer, Bonn, Germany)

2003 – 2004

Stipend from the Hertie Foundation (Excellence Program in Neurosciences)

2002

Organon Prize for Psychiatry

1990 – 1994

Fellowships from the Swiss National Foundation

 

Transparenz / Erklärung von Interessen

Herr Professor Dr. Beat Lutz ist seit 2004 Professor für physiologische Chemie an der Universitätsmedizin Mainz, dort Direktor des Instituts für Physiologische Chemie und seit 2020 wissenschaftlicher Direktor und Arbeitsgruppenleiter am Leibniz-Institut für Resilienzforschung. Er hat seit 2018 keine persönlichen Honorare für Beratertätigkeiten, Fortbildungsveranstaltungen, Vorträge oder Stellungnahmen von pharmazeutischen Unternehmen oder Medizinprodukteherstellern erhalten. Von der gemeinnützigen Boehringer Ingelheim Stiftung erhielt Prof. Lutz zusammen mit anderen Wissenschaftlerinnen und Wissenschaftlern Forschungsmittel für die Jahre 2017-2020 zum Aufbau des Leibniz-Instituts für Resilienzforschung.

Selected Publications

Busquets-Garcia A, Gomis-Gonzalez M, Srivastava RK, Cutando L, Ortega-Alvaro A, Ruehle S, Remmers F, Bindila L, Bellocchio L, Marsicano G, Lutz B*, Maldonado R*, Ozaita A* (2016) Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. Proc Natl Acad Sci USA 113(35):9904−9909. *equal contribution

>> Link zu Pubmed

Domingo-Rodriguez L, Ruiz de Azua I, Dominguez E, Senabre E, Serra I, Kummer S, Navandar M, Baddenhausen S, Hofmann C, Andero R, Gerber S, Navarrete M, Dierssen M, Lutz B*, Martín-García E*, Maldonado R* (2020) A specific prelimbic-nucleus accumbens pathway controls resilience versus vulnerability to food addiction. Nat Commun 11(1):782. doi: 10.1038/s41467-020-14458-y. (*equal contributions)

>> Link zu Pubmed

Lange MD, Daldrup T, Remmers F, Szkudlarek HJ, Lesting J, Guggenhuber S, Ruehle S, Jungling K, Sei-denbecher T, Lutz B, Pape HC (2017) Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat. Mol Psychiatry 22(10):1422−1430.

>> Link zu Pubmed

Leschik J, Gentile A, Cicek C, Péron S, Tevosian M, Beer A, Radyushkin K, Bludau A, Ebner K, Neumann I, Singewald N, Berninger B, Lessmann V, Lutz B (2022) Brain-derived neurotrophic factor expression in serotonergic neurons improves stress resilience and promotes adult hippocampal neurogenesis. Prog Neurobiol 217:102333. doi: 10.1016/j.pneurobio.2022.102333.

>> Link zu Pubmed

Lomazzo E, Bindila L, Remmers F, Lerner R, Schwitter C, Hoheisel U, Lutz B (2015) Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacol 40:488-501.

>> Link zu Pubmed

Marsicano G, Wotjak CW, Azad SC, Bisogno T, Rammes G, Song T, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530-5.

>> Link zu Pubmed

Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wolfel B, Dodt HU, Zieglgänsberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B (2006) The endocanna-binoid system controls key epileptogenic circuits in the hippocampus. Neuron 51:455−466.

>> Link zu Pubmed

Rey AA, Purrio M, Viveros MP, Lutz B (2012) Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacol 37:2624–34.

>> Link zu Pubmed

Ruiz de Azua I, Mancini G, Srivastava RK, Rey AA, Cardinal P, Tedesco L, Zingaretti CM, Sassmann A, Quarta C, Schwitter C, Conrad A, Wettschureck N, Vemuri VK, Makriyannis A, Hartwig J, Mendez-Lago M, Bindila L, Monory K, Giordano A, Cinti S, Marsicano G, Offermanns S, Nisoli E, Pagotto U, Cota D, Lutz B (2017) Adipocyte cannabinoid receptor CB1 regulates energy homeostasis and alternatively activated macrophages. J Clin Invest 127(11):4148−4162

>> Link zu Pubmed

Vennin C, Hewel C, Todorov H, Wendelmuth M, Radyushkin K, Heimbach A, Horenko I, Ayash S, Müller MB, Schweiger S, Gerber S, Lutz B (2022) A Resilience Related Glial-Neurovascular Network Is Transcriptionally Activated after Chronic Social Defeat in Male Mice. Cells 11(21):3405. doi: 10.3390/cells11213405.Pascual Cuadrado D, Todorov H, Lerner R, Islami L, Bindila L, Gerber S, Lutz B (2022) Long-term molecular differences between resilient and susceptible mice after a single traumatic exposure. Br J Pharmacol 179(17):4161-4180. doi: 10.1111/bph.15697.

>> Link zu Pubmed
Cookie-Einstellungen:
Sie können Ihre Cookie-Einstellungen jederzeit im Footer dieser Website ändern.